The topical provides a daily surface-level dose to the face and neck
The nervous system data is thin compared to the wound healing research, but it keeps this peptide on the radar for neuroscience-adjacent work
The overall treatment discontinuation rate is lower with cagrilintide (about 1%) compared to semaglutide (5-7%)
He L, Feng D, Guo H, Zhou Y, Li Z, Zhang K, et al
exemplary subjects or patients which might benefit from receiving therapy such as administration of the one or more HGF mimics described herein are generally mammals, and usually humans, although this need not always be the case, since veterinary and research related applications of the technology are also contemplated